Works matching IS 08991987 AND DT 2023 AND VI 62 AND IP 7

Results: 16

Withaferin A inhibits breast cancer‐induced osteoclast differentiation.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1051, doi. 10.1002/mc.23545

By:

Hahm, Eun‐Ryeong;
Kim, Su‐Hyeong;
Singh, Shivendra V.

Publication type:

Article

Heterogeneity in the immune microenvironment of bone metastasis in driver‐positive non‐small cell lung cancer.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1001, doi. 10.1002/mc.23541

By:

Yang, Xiao‐Rong;
Pi, Can;
Zhang, Yi‐Chen;
Chen, Zhi‐Hong;
Zhang, Xu‐Chao;
Zhu, Dong‐Qin;
Yang, Ling‐Ling;
Yin, Jiani C.;
Deng, Jia‐Yi;
Yang, Ming‐Yi;
Luo, Wei‐Chi;
Wu, Yi‐Long;
Zhou, Qing

Publication type:

Article

Transcriptomic identification of differentially expressed genes in Levonorgestrel resistant endometrial cancer cell lines.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1038, doi. 10.1002/mc.23544

By:

Dore, Molly;
Faya, Ngonidzashe;
Filoche, Sara;
Henry, Claire

Publication type:

Article

Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR‐1343‐3p/Bcl‐3 axis through TGFβ/Smad3/EMT signaling.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1073, doi. 10.1002/mc.23547

By:

Ge, Peng;
Chen, Xin;
Liu, Juan;
Jing, Ruijun;
Zhang, Xingxing;
Li, Hanjie

Publication type:

Article

Ubiquitin ligase MARCH8 promotes the malignant progression of hepatocellular carcinoma through PTEN ubiquitination and degradation.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1062, doi. 10.1002/mc.23546

By:

Xu, Yingchen;
Zhang, Dongxin;
Ji, Jiajun;
Zhang, Lijun

Publication type:

Article

MYO1B as a prognostic biomarker and a therapeutic target in Arecoline‐associated oral carcinoma.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 920, doi. 10.1002/mc.23535

By:

Sun, Zhen;
Guo, Xiaopeng;
Chen, Huarong;
Ling, Junjun;
Zhao, Houyu;
Chang, Aoshuang;
Zhuo, Xianlu

Publication type:

Article

Targeted therapy using larotrectinib and venetoclax for the relapsed/refractory T‐cell acute lymphoblastic leukemia harboring a cryptic ETV6‐NTRK3 fusion.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 899, doi. 10.1002/mc.23534

By:

Zhou, Kuangguo;
Gong, Duanhao;
He, Cheng;
Xiao, Min;
Zhang, Meilan;
Huang, Wei

Publication type:

Article

PDK1‐stabilized LncRNA SPRY4‐IT1 promotes breast cancer progression via activating NF‐κB signaling pathway.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1009, doi. 10.1002/mc.23542

By:

Zhang, Yulu;
Chen, Hongling;
Yuan, Renjie;
Wang, Yange;
Zhang, Dian;
Zeng, Qian;
Jiang, Weiqian;
Zhang, Ruiming;
Chen, Tingmei;
Chai, Chengsen;
Guo, Bianqin

Publication type:

Article

PCBP1 protects bladder cancer cells from mitochondria injury and ferroptosis by inducing LACTB mRNA degradation.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 907, doi. 10.1002/mc.23533

By:

Luo, Yang;
Zhang, Yunli;
Pang, Shiyu;
Min, Jingxian;
Wang, Tao;
Wu, Dali;
Lin, Chun;
Xiao, Zebin;
Xiang, Qi;
Li, Qing;
Ma, Lili

Publication type:

Article

Translational relevance of SOS1 targeting for KRAS‐mutant colorectal cancer.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1025, doi. 10.1002/mc.23543

By:

Alem, Diego;
Yang, Xinrui;
Beato, Francisca;
Sarcar, Bhaswati;
Tassielli, Alexandra F.;
Dai, Ruifan;
Hogenson, Tara L.;
Park, Margaret A.;
Jiang, Kun;
Cai, Jianfeng;
Yuan, Yu;
Fernandez‐Zapico, Martin E.;
Tan, Aik Choon;
Fleming, Jason B.;
Xie, Hao

Publication type:

Article

Predictive significance of PRR11 in prognosis and immune infiltration of glioma patients.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 975, doi. 10.1002/mc.23539

By:

Han, Wei;
Chen, Liang

Publication type:

Article

LATS‐regulated nuclear‐cytoplasmic translocation of SREBP2 inhibits hepatocellular carcinoma cell migration and invasion via epithelial–mesenchymal transition.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 963, doi. 10.1002/mc.23538

By:

Zhang, Feng;
Gao, Jie;
Liu, Xudong;
Sun, Yaohui;
Liu, Long;
Hu, Bowen;
Wang, Zhihui;
Shi, Jihua;
Guo, Wenzhi;
Zhang, Shuijun

Publication type:

Article

A variant in CYP26B1 associated with esophageal squamous cell carcinoma risk by affecting retinoic acid metabolism.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 991, doi. 10.1002/mc.23540

By:

Niu, Siyuan;
Shi, Ke;
Yue, Xinying;
Pan, Miaoxin;
Song, Lina;
Gu, Linglong;
Tan, Yuqian;
Miao, Xiaoping;
Tian, Jianbo;
Chang, Jiang

Publication type:

Article

Dual role of sprouty2 as an inhibitor of RAS/ERK‐driven proliferation and a promoter of cancer invasion in KRAS wild‐type colorectal cancer.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 951, doi. 10.1002/mc.23537

By:

Lee, Chung‐Ta;
Chu, Chien‐An;
Wang, Yu‐Ming;
Wang, Yi‐Wen;
Chen, Yi‐Lin;
Ho, Chung‐Liang;
Yeh, Yu‐Min;
Lin, Peng‐Chan;
Lin, Bo‐Wen;
Chen, Po‐Chuan;
Chen, Shang‐Hung;
Chan, Ren‐Hao;
Chang, Chen;
Chow, Nan‐Haw

Publication type:

Article

Targeting SMYD2 inhibits prostate cancer cell growth by regulating c‐Myc signaling.

Published in:

Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 940, doi. 10.1002/mc.23536

By:

Li, Junhong;
Wan, Fangning;
Zhang, Junyu;
Zheng, Shengfeng;
Yang, Yunjie;
Hong, Zhe;
Dai, Bo

Publication type:

Article

Issue Information ‐ Ed Board.

Published in:: Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 895, doi. 10.1002/mc.23429
Publication type:: Article